Section 32 (S32)
Tier 3 Industrial
Bio
Section 32 (S32) Section 32 was founded by Bill Maris, who previously created Google Ventures and shaped its early investment thesis. Now managing $2.3B across 5 funds including a $525M Fund 5 (2023), S32 invests at the frontiers of technology and life sciences across all stages. The portfolio of 70+ investments includes marquee exits: Coinbase (IPO), CrowdStrike (IPO), Relay Therapeutics (Nasdaq listing), Vir Biotechnology, and Thrive Earlier Detection (acquired by Exact Sciences). The sector c
Industries
BiotechMedTechAI InfrastructureClimate TechSpace Tech
Stages
SeedSeries A
Geography
US
Notable investments
- Coinbase
- CrowdStrike
- Relay Therapeutics
- Vir Biotechnology
- Thrive Earlier Detection